
Devonian Reports Encouraging In-Vivo Findings on Thykamine’s Impact on Fibrosis-Related Gene Expression
Devonian Health Group’s Thykamine™ Shows Positive Results in STAM™ Mouse Model Quebec City, Canada – Devonian Health Group Inc. (Devonian or the Company), a clinical-stage biopharmaceutical corporation dedicated to creating innovative treatments for inflammatory diseases, recently announced promising findings from a gene analysis conducted as part of an in vivo study using the STAM™ mouse…